Nomura Holdings
TXG icon

Nomura Holdings’s 10x Genomics TXG Stock Holding History

Nomura Holdings’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Sell
28,585
-48,451
-63% -$1.27M ﹤0.01% 1332
2026
Q1 		$1.64M Sell
77,036
-248,747
-76% -$4.97M ﹤0.01% 990
2025
Q4 		$5.31M Buy
+325,783
New +$4.92M 0.01% 746
2023
Q2 		– Sell
-8,750
Closed -$488K – 1640
2023
Q1 		$488K Sell
8,750
-57,850
-87% -$2.7M ﹤0.01% 1139
2022
Q4 		$2.42M Buy
+66,600
New +$2.18M 0.01% 669

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nomura Holdings's TXG Position: Q2 2026 in Review

Nomura Holdings reduced its 10x Genomics (TXG) stake by 63% in Q2 2026, selling an estimated $1.27M and leaving 28,585 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

Nomura Holdings first reported a position in TXG in Q4 2022 and has held it in 5 quarters since. The position peaked at $5.31M in Q4 2025. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Nomura Holdings held 28,585 shares of 10x Genomics worth $1.1M as of Q2 2026.
  • Nomura Holdings sold 48,451 10x Genomics shares in Q2 2026, an estimated $1.27M.
  • 10x Genomics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1332 holding.
  • Nomura Holdings first reported a position in 10x Genomics in Q4 2022 and has held it in 5 quarters since.
  • Nomura Holdings's 10x Genomics position peaked at $5.31M in Q4 2025.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.